Back to Search
Start Over
WS05.03 A phase 3b study of the effects of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on glucose tolerance in people with cystic fibrosis (CF) and abnormal glucose metabolism.
- Source :
-
Journal of Cystic Fibrosis . Jun2023:Supplement 2, Vol. 22, pS10-S10. 1p. - Publication Year :
- 2023
- Subjects :
- *GLUCOSE metabolism
*CYSTIC fibrosis
*GLUCOSE
Subjects
Details
- Language :
- English
- ISSN :
- 15691993
- Volume :
- 22
- Database :
- Academic Search Index
- Journal :
- Journal of Cystic Fibrosis
- Publication Type :
- Academic Journal
- Accession number :
- 164181364
- Full Text :
- https://doi.org/10.1016/S1569-1993(23)00213-8